HTC-C3

Cat.No.: CSC-C0585

Species: Human

Source: thyroid carcinoma

Morphology: epithelial-like cells growing as monolayer

Culture Properties: monolayer

Inquire for Price

Specification
Q & A
Customer Review

Cat.No.

CSC-C0585

Description

Established from cancer cells disseminated in the pleural fluid of a 44-year-old woman with undifferentiated giant cell carcinoma of the thyroid after chemotherapy, x-ray hyperthermia and OK432 injections in 1986; cells were described to contain parathyroid-like activity

Species

Human

Source

thyroid carcinoma

Recommended Medium

80% DMEM + 20% h.i.FBS

Culture Properties

monolayer

Morphology

epithelial-like cells growing as monolayer

Karyotype

Human near-triploid karyotype with 23% polyploidy - 68(68-73)<3n>XXXXX, add(X)(p11), add(X)(p11)add(X)(q11), add(X)(q11), del(X)(p11), der(6)t(X;6)(q23;q25), inc.

Quality Control

Mycoplasma: contamination was eliminated with enrofloxacin (Baytril), then negative in microbiological culture, PCR assays
Immunology: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, desmin -, endothel -, GFAP -, neur

Storage and Shipping

Frozen with 70% medium, 20% FBS, 10% DMSO at about 0.4-0.5 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

How can thyroid tumor cell cultures contribute to the development of personalized therapies for thyroid cancer patients?

Thyroid tumor cell cultures can be used to evaluate the response of individual patient cells to different treatments, including chemotherapy, targeted therapies, or immunotherapies. This information can help guide treatment decisions and develop personalized therapeutic approaches for thyroid cancer patients based on their specific genetic and molecular characteristics.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

A great choice

I purchased this cell product for tissue engineering purposes, and it was a great choice.

02 Oct 2023

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1010X

CS-001Y

FTC-133

Description: FTC-133 was isolated from a lymph node metastasis of a follicular thyroid carcinoma. The morphology differs from flat polygonal to spindle formed cells. They retained differentiated thyrocyte function and thyrocyte responsiveness to thyrotropin and local active growth factors. Thyroglobulin immunoreactivity could be shown in the cytoplasm and EGF receptor immunoreactivity could be visualised on the cell membranes. Complex chromosomal changes were detected as well as a p53 mutation.

Cat#: CSC-6254W INQUIRY

View Product

FTC-238

Description: Species: human male 42 years old;
Tissue: thyroid;
Tumor: carcinoma, follicular;
Derived from: lung metastasis

Cat#: CSC-6255W INQUIRY

View Product

RO82-W-1

Description: Species: human;
Tissue: thyroid;
Tumor: carcinoma, follicular

Cat#: CSC-6309W INQUIRY

View Product

8305C

Description: Established from the primary tumor of a 67-year-old woman with primary thyroid carcinoma (undifferentiated carcinoma, composed of spindle, polygonal and giant cells)

Cat#: CSC-C0290 INQUIRY

View Product

S-117

Description: Established from the sarcoma of the thyroid gland from a 47-year-old woman in 1985

Cat#: CSC-C0365 INQUIRY

View Product

B-CPAP

Description: Established from the tumor tissue of a 76-year-old woman with metastasizing papillary thyroid carcinoma in 1992

Cat#: CSC-C0370 INQUIRY

View Product

For research use only. Not for any other purpose.